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ABSTRACT 
Sea lice (Lepeophtheirus salmonis) are the most costly parasitic infestation in the culture of 
Atlantic salmon (Salmo salar) with control strategies relying heavily on the use of a limited 
number of chemotherapeutants and traditional univariate analytical tools to evaluate and 
optimize their delivery. Azamethiphos (Salmosan®) is a powerful delousing agent, which has 
been administered as a topical treatment using three different modalities: skirt-style enclosures, 
fully-enclosed tarpaulin enclosures and wellboats. In this study, we analyzed and evaluated the 
efficacy of azamethiphos treatments between these three modalities against PAAM (pre-adult 
males and females and, adult males) and adult female stages using a multivariate approach. The 
exploratory analysis revealed efficacy in the fully-enclosed tarpaulin modality to be 2.2 times 
greater compared to skirt-style and wellboat modalities; whereas efficacy against adult females 
in the wellboat modality was two times larger than in the other modalities. Using the multivariate 
analysis, treatment efficacy in the fully-enclosed tarpaulin modality was greater than the skirt-
style modality, but no significant differences were observed between the wellboat and skirt 
modalities. These results should be interpreted with caution as differences existed in the 
abundances and proportions of sea lice stages before treatment that may affect the observed 
treatment efficacies. For an evaluation and comparison of treatment modalities, multivariate 
techniques offer added advantages over the more traditional univariate methods, in that 
simultaneous analysis of multiple sea lice stages and any dependencies or correlation between 
these stages can be effectively addressed.  
 
 
1. INTRODUCTION 
 
Severe infestations by the sea louse Lepeophtheirus salmonis can incur significant health, 
production and market value costs for the Atlantic salmon (Salmo salar) aquaculture industry as 
a result of damage to the fish, treatment costs, potential impacts of treatments on non-target 
species, and public perceptions of aquaculture (Costello, 1993; Pike & Wadsworth, 1999; 
Costello et al., 2001; Haya et al., 2005; Costello, 2009). To date, successful control of sea lice 
infestations rely heavily on effective delousing through the use of a variety of in-feed and bath-
administered chemotherapeutants (Pike & Wadsworth, 1999; Boxaspen, 2006; Brooks, 2009). 
Inappropriate administration of therapeutants and reliance on individual therapeutants targeting 
specific life cycle stages can result in treatment failure and increase the risk of resistance 
developing in sea lice populations (Bloland & Ettling, 1999). Resistance has already been 
observed for chemotherapeutants in geographical areas where salmonids are intensively cultured 
(Jones et al., 1992; Tully and McFadden, 2000; Treasurer et al., 2000; Denholm et al., 2002; 
Sevatdal & Horsberg, 2003; Fallang et al., 2004; Bravo et al., 2008; Lees et al., 2008; Jones et 
al., 2013; Whyte et al., 2013; 2014; Grøntvedt et al., 2014).   
 
In the Bay of Fundy aquaculture region of southwestern New Brunswick, Canada, the synthetic 
organophosphate pesticide, azamethiphos (Salmosan®) has been available for use, as a topical 
treatment for sea lice, for the greater part of 20 years. It was however, used sparingly between 
2000 and 2009 due to the predominant use of emamectin benzoate. Salmosan® affects pre-adult 
and adult sea lice stages but is less effective against the juvenile stages. The active ingredient, 
azamethiphos, acts as an inhibitor of cholinesterase producing a continuous excitatory state in the 
parasite eventually causing irreparable nerve damage and death (Dutertre & Lewis, 2006). Fish 
are topically exposed via a bath treatment which is the most frequently used modality for 
delousing larger fish.  
 
During the study period, three treatment modalities were available to administer bath treatments 
of azamethiphos at aquaculture cages sites in New Brunswick; skirt-style tarpaulin (semi-open) 
enclosures, fully-enclosed tarpaulin enclosures, and wellboats (closed system). The skirt-style 
enclosure was most utilized due to the relative ease and rapidity of access to equipment and 
materials. However, it was problematic for large cages or in strong tidal currents, produced 
variable and non-uniform distribution of the therapeutant in the cage and allowed therapeutant to 
escape through the open bottom. Not surprisingly, treatments performed with skirt style-
enclosures have been shown to be much less effective than with fully-enclosed tarpaulins 
(SEARCH Consortium, 2006; Fridell, 2009; Corner et al., 2011). The fully-enclosed tarpaulin 
modality is often recommended or mandatory for bath treatments in many countries (Corner et 
al. 2007; Finne-Fridell et al., 2012; NASCO, 2010), providing a more uniform distribution of 
therapeutant due to the more defined treatment volume. Technical challenges, however, exist 
when used with large cages (90m - 120m in circumference), or at sites that maintain high current 
flow, and additional resources (personnel and time) are required for set up, with increased risk 
for potential complications (Corner et al., 2007).  Both modalities can be stressful to the crowded 
fish, with a possible residual presence of the therapeutant within the cage once the tarpaulin has 
been removed, or absorbance of the therapeutant by organic debris in the water column and 
biofouling on the nets (Treasurer et al., 2000; Costello, 2009).  
 
Wellboat use was introduced into New Brunswick in 2010 (ACFFA, 2011). The espoused 
benefits of the wellboat include increased efficacy, reduced amount of, and increased precision 
in, the therapeutic dose administered and, reduced release of chemical that can affect non-target 
organisms (ACFFA, 2011; Page and Burridge, 2014). Multiple treatments may, however, be 
required to completely expose one cage to the therapeutant since wellboat applications are 
dependent on the well volume and the size and number of fish in the cage. While the 
concentration of chemotherapeutant reaching the environment is diluted as the well is flushed 
(Page et al., 2014; Ernst et al., 2014), the discharged effluent is often in the vicinity of the cages 
and surviving lice within the discharge could potentially increase the risk of transmission of sea-
lice or other pathogens between and within farms. This risk is similar for the skirt-style and 
fully-enclosed tarpaulin modalities where the residual treatment disperses naturally via the 
current. Due to the limited availability and expense of operating these vessels, there is continual 
effort to enhance delivery of therapeutants via the fully-enclosed tarpaulin modality through 
improved dosing systems which provide more predictable and consistent exposure. 
 
Analytical tools for evaluating and optimizing the delivery of chemotherapeutants are important 
for standardization and implementation of good management practices for the control of sea lice 
infections. The aim of this study was to utilize a multivariate approach to concurrently evaluate 
and compare the effectiveness of azamethiphos against all life cycle stages of the salmon louse 
between the three different modalities of treatments. This is important in studies using field data, 
where sampling (methods and type of data collected) does not always follow a standardized 
procedure and, as such, evaluation of treatment effect is often limited by the availability and the 
asymmetry of the collected data. The estimation of effects is therefore subject to sampling and 
misclassification biases and lack of control of confounders (e.g. water temperatures, salinity).  
Since many factors modulate the mortality, transmission (infectivity) and maturation (moulting) 
of sea lice (Ramette, 2007; Jimenez et al., 2013), the proportion of sea lice stages observed after 
treatment will vary under differing field conditions. Therefore, we suggest that it may be more 
meaningful to evaluate treatment effectiveness by considering all sea lice stages concurrently. 
 
2. MATERIALS AND METHODS 
 
2.1 Sea Lice Categorization 
The sea lice monitoring program in New Brunswick requires lice to be categorized by stage 
(juvenile, pre-adult and adult) and sex (male and female).  The sea lice categories used are: [1] 
Chalimus (stages I and II); [2] Pre-adult (stages I and II) (male and female) and adult male lice 
(PAAM) (Whyte et al., 2014); and [3] Adult female lice (gravid and non-gravid) (AF).  
 
2.2 Sea Lice Monitoring and Treatment Efficacy  
Sea lice abundance and response to azamethiphos treatment under field conditions of use were 
examined by performing pre-treatment and post-treatment counts. These counts have shown to 
be reproducible and were applied in a similar manner across the New Brunswick industry 
(Elmoslemany et al., 2013). Atlantic salmon (Salmo salar) aquaculture sites in the Bay of Fundy, 
which received treatments with azamethiphos during the period 2010 to 2013, were identified 
and assessed for sea lice numbers, as part of an integrated sea lice monitoring program. Sites 
receiving treatment were chosen by company managers and veterinarians based on sea lice 
abundance. The proportion of treated/non-treated cages was not specified and no randomized 
comparisons or untreated control cages / sites were available. Mean cage and treatment event 
levels of sea lice abundance were estimated based on samples of 5-10 fish per cage from at least 
6 cages at each site by a generalized linear mixed effects model (GLMM) fit to counts of 
Lepeophtheirus salmonis. Counts were performed on each cage as close to the treatment day as 
possible, and at no point more than 5 days prior to treatment (pre-treatment count) as well as, 
potentially, multiple times within the 14 day period following each treatment (post-treatment 
counts).  Pre- and post-treatment count data were available for treatment events involving a total 
of 178 cages from 24 separate sites within the Bay of Fundy. Counting of all cages would usually 
occur on the same day but as treatment days differed slightly cages were often measured at 
different days post-treatment depending on the day of treatment.  
 
Skirt-style enclosures were open to limited water exchange, unlike the enclosed tarpaulin which 
completely enveloped the cage. Either method involved deployment of a tarpaulin barrier prior to 
administering the therapeutant into the net pen for the prescribed period. Following treatment, 
removal of the tarpaulin allowed the therapeutant to disperse into the surrounding water by the 
action of the tide, waves and currents. Wellboat treatments were conducted by pumping the fish 
from the cage into treatment wells filled with sea water in the wellboat. The prescribed amount 
of chemotherapeutant was added to each well and fish were monitored. Following the prescribed 
treatment time, the wells were flushed with clean sea water, to reduce and eventually 
eliminate the concentration of therapeutant, and the effluent was discharged into the surrounding 
water. After a rest period, the fish were returned to the sea cage. The prescribed treatment dose 
of Salmosan® for wellboat or enclosed tarpaulin treatments was 200 parts per billion (ppb) and 
300 ppb for skirt treatments. The duration of exposure was 60 minutes when the water 
temperature was below 10°C, and 30 minutes when the water temperature was above 10°C, at the 
discretion of the prescribing veterinarian.  
 
Fish sampled for sea lice abundance counts were collected using a sample procedure involving 
capture (with a dip-net) of fish attracted to the surface with feed, followed by anesthesia using 
tricaine methane sulphonate (TMS; Syndel Laboratories), at a dose of approximately 100 mg l-1. 
Each stage of lice was counted and recorded on a per-fish basis.  The percentage knock-down 
values for sea lice were estimated based on the number of lice recorded during the pre-treatment 
count conducted closest to the time of azamethiphos treatment (when there was more than one 
count) and the weekly average count in the first and second post-treatment weeks.  
 
2.3 Exploratory Analysis 
The dataset included cages for which matching pre- and post-treatment counts were available. In 
New Brunswick, post-treatment sea lice counts should be repeated on the same cages as for the 
pre-treatment count. In practice, however, management constraints sometimes result in counts 
from non-matched cages, (i.e. there exists either a pre-treatment count or a post-treatment count 
but not both). Only matched cage data was considered in this study.  
 
The correlation of abundances among taxa data: scatter plot matrices of transformed abundances 
(before and after treatment) was also performed. Exploratory multivariate analysis using 
ordination methods were employed to simultaneously evaluate the effects of azamethiphos 
treatment in different sea lice stages. A diagrammatic representation of the different patterns 
representing the assemblages of sea lice stages for each cage, before and after treatment, was 
generated. To visualize pattern differences between sampling times for each treatment modality, 
we utilized principal component analysis (PCA), after standardizing abundances from all three 
sea lice stages to unit variance, to obtain a more balanced ordination. Principal component 
analysis excluded missing data for eight treatments (n=21); five skirt-style, one wellboat and one 
tarpaulin treatment where counts for chalimus stages had not been recorded.   
 
2.4 Statistical Analysis 
 
2.4.1 Exploratory analysis for treatment effectiveness 
 
If more than two fish per cage had counts greater than 100 lice, the data for this cage were 
excluded from the analysis as there was no way to accurately estimate the actual number of lice 
on the fish (Elmoslemany et al., 2013). This circumstance occurred rarely and resulted in the 
exclusion of only two cage treatment records. The percentage knockdown value based on the 
pre- and post-treatment count values (i.e. the proportion of the difference in counts before and 
after treatment divided by the count before treatment), and the 95% confidence interval was 
estimated using the quasi-Poisson method (Jimenez et al., 2012) calculated in R using the 
pairwise CI package (R Development Core Team, 2008).  For the purpose of the analysis, 
treatment effectiveness (% knockdown) for each sea lice stage was modeled. Treatment 
effectiveness was set to zero when percent knockdown values were negative.  
 
2.4.2 Univariate (multivariable) statistical analysis  
Two models were developed for the post-treatment counts of PAAMj and AFj, where j 
represents the cage treatment using a negative binomial model. The negative binomial model was 
selected to account for over-dispersion in the data. For modeling counts of PAAM and AF, we 
multiplied by the number of fish sampled (typically 10) and rounded to the nearest integer. Zero 
counts of PAAM or AF represented less that 1% of the data. The data included pre-treatment 
abundances of PAAM and AF, modality of treatment and the interval (in days) between 
treatment and sampling. Pre-treatment abundances were transformed with a natural logarithm as 
it best described how the model predicted/ explained the observed data. 7KHFRYDULDWHV¶SUH-
treatment abundances and count day interval were also centered. Random effects were tested to 
account for treatment event and locality and model selection was undertaken uVLQJ$NDLNH¶V
information criteria (Zuur, 2009). For model validation, standardized residuals were plotted 
against all the explanatory variables using the package glmmADMB (Fournier et al., 2012; 
Skaug et al., 2013) in R, version 3.1.2 (R Development Core Team, 2014). Post-treatment counts 
of chalimus were not included in the model, as no treatment effect was observed against 
chalimus stages in the skirt or wellboat modalities. Although there may be an influence of 
availability of each treatment modality in any given year (e.g. skirt treatments were discontinued 
in 2011), levels of sea lice were much higher in the skirt and wellboat modalities than in the 
tarpaulin modality, possibly suggesting a greater infection pressure. We were, however, unable 
to account for this in our model due to a lack of environmental data, e.g. water temperatures, 
infection pressure from neighboring cages or localities. In addition, chalimus stages are often 
overlooked due to their very small size, with field counts of chalimus stages often 
underestimated by up to 40% (Schram, 1993; Beamish et al., 2005; Elmoslemany et al., 2013).   
 
2.4.3 Multivariate analysis  
A generalized linear model with a multivariate extension (Warton, 2011) was utilized for the 
multivariate analysis. This included a negative binomial regression which is appropriate for this 
type of data since the mean-variance function of counts is often quadratic. The analysis was 
performed using the open source mvabund package in R (Wang et. al., 2012). 
 
A model based approach was taken to test the effect of treatment modalities after controlling for 
pre-treatment abundances of sea lice and the interval of days between treatment and post-
treatment sampling, using the function manyglm in the R package mvabund version 3.8.4. 
(Wang et al., 2012). This approach allows us to make inferences on sea lice community and 
composition within the cage by fitting separate GLMs to each variable, using a set of explanatory 
variables, and testing significance through re-sampling-based hypothesis testing (Wang et al., 
2012). Negative binomial GLMs were conducted with a two dimensional matrix of the PAAM 
and AF assemblage composition in the cages following treatment as the dependent variable, with 
the covariates, pre-treatment abundances of PAAM and AF, modality of treatment and post-
treatment sampling interval as independent variables. The models were tested using the ANOVA 
function in the mvabund, providing a multivariate test for community and each louse stage 
(PAAM and AF) post-treatment. Wald test statistics (Nooten et al., 2014), were constructed, 
assuming correlation (matrix shrink by parameter 0.84), to allow for correlated responses among 
sea lice assemblages. P-values were calculated using 999 re-sampling iterations via trap re-
sampling (Wang et al., 2012). The analysis was performed at the level of the cage. 
 
3.0 RESULTS 
This study included a total of 178 cage treatments comprised of 110 skirt-style enclosures, 20 
fully-enclosed tarpaulin and 48 wellboat treatments conducted during the period 2010 to 2013.  
Approximately 90% of the locations (and 152 of the 178 cages) performed treatments using a 
single modality, but at five locations they simultaneously performed cage treatments using a 
mixture of skirts (n=19) and fully-enclosed tarpaulins (n=7). The number of cages sampled pre- 
and post-treatment at each site ranged between one and five for the wellboat and enclosed-
tarpaulin modalities, and from 1 to 9 for the skirt-style modality.   
 
During the period under study, the level of infection happened to be lower in cages using the 
fully-enclosed tarpaulin treatment modality, when compared to the wellboat and skirt-style 
modalities. Figure 1 illustrates the differences in proportions of sea lice based on the median 
values calculated for each stage within the three treatment modalities at pre-treatment, one week 
post-treatment and two weeks post-treatment. For example, the level of infection at any sampling 
time was larger in the wellboat modality compared to the other two treatment modalities, 
particularly for the chalimus and adult female stages. The proportion of PAAM is also larger 
compared to the chalimus and AF stages in the fully-enclosed tarpaulin and skirt-style 
modalities, whereas, in the wellboat modality, the proportions of all three sea lice stages are 
more alike. These differences in the initial levels and proportion across treatment modalities will 
likely influence the observed post-treatment levels of sea lice. 
 
Treatment was observed to be effective at varying levels against mobile stages (PAAM and AF) 
in all three modalities. The greatest reductions in post-treatment abundances of PAAM and AF 
were observed in the fully-enclosed tarpaulin and wellboat modalities (Table 1).  Azamethiphos 
treatment was not, however, effective against chalimus in either the skirt-style or wellboat 
modalities. Treatment effect also appeared to be greater for all stages in the fully-enclosed 
tarpaulin modality in the second week post-treatment compared to the first week (Table 1).  
 
In contrast, chalimus and PAAM abundances increased in the second week post-treatment in the 
skirt-style and fully-enclosed tarpaulin modalities, which was reflected in a reduction of the 
treatment efficacy at week two post-treatment. In the wellboat modality, the treatment effect was 
sustained only for adult female sea lice, most likely as a result of the fact that at least two weeks 
are required for surviving chalimus to moult into adult females. Chalimus are difficult to predict 
since their arrival will at least partially depend on external infection pressure, which is not 
known. 
 
Changes in sea lice stage composition from pre- to post-treatment for the three treatment 
modalities, analyzed using ordination plot analyses, revealed the largest spread in the fully-
enclosed tarpaulin modality with the greatest spread being along the horizontal axis, in the 
chalimus and PAAM stages (Figure 2a). A lesser separation was observed between pre- and 
post-treatment counts in the wellboat modality, along the PAAM and AF planes (Figure 2b). In 
contrast, the large amount of overlapping in the skirt-style modality indicates fewer differences 
in the composition of sea lice assemblages before and after treatment (Figure 2c).  
 
Results from the univariate statistical models indicate a 30% (p < 0.05) post-treatment reduction 
in abundances of PAAM lice and a 20% reduction in abundances of AF lice (p = 0.09) in the 
fully-enclosed tarpaulin, compared to the skirt-style modality, after controlling for pre-treatment 
levels and time interval (Table 2a & b). No significant differences were observed between the 
skirt-style and wellboat modalities. In comparison, the multivariate analyses indicated that the 
assemblage composition of sea lice stages RUµSUH-WUHDWPHQWSURILOH¶ was significantly different 
between the fully-enclosed tarpaulin and the skirt-style modalities (p = 0.02), but not 
significantly different when comparing the wellboat and skirt-style modalities (p = 0.344) (Table 
3). Pre-treatment abundances of PAAM and AF lice and the interval of days post-treatment when 
the sea lice count was taken were significant and positively associated with the post-treatment 
counts of PAAM and AF lice. 
  
4. DISCUSSION 
 
Research have shown that treatment efficacies vary against different lice stages (Wootten et 
al.,1982; Branson et al., 2000; Sevadtal et al., 2005; Whyte et al., 2014). The practice of 
monitoring clinical treatment response through the analysis of field-collected data is a key factor 
in the detection of changes in treatment effectiveness. Treating at the appropriate time, based on 
the assemblage of sea lice stages observed during monitoring, is a relevant consideration for 
controlling sea lice levels. In reality, however, these issues are difficult to resolve as the trigger 
for management action, usually treatment, in many farming regions is dependent on exceeding 
an established threshold of sea lice numbers (particularly adult female lice) and is independent of 
the composition of lice assemblages (SEARCH Consortium 2006; Norwegian Food Safety 
Authority. 2010; Code of Good Practice Management Group 2010; DFO, 2014). For this reason, 
we believe that multivariate analysis is a more appropriate approach when analyzing these data 
since the univariate test only evaluates the effect of treatment on one stage or subgroup of sea 
lice assemblages. Also, the results from separate tests cannot be correctly interpreted, as the 
effect of the therapeutant is correlated among the different sea lice stages. Multivariate analyses 
are now commonly utilized in the analysis of ecological data (Dray et al., 2012; Buttigieg & 
Ramette, 2014) and incorporate a generalized linear approach (Wang et al., 2012) to overcome 
the limitations commonly found with classical multivariate tests such as MANOVA.  
 
In this study, a multivariate approach was used to highlight differences in the efficacy of 
azamethiphos across different bath modalities. All treatment modalities exhibited greater 
effectiveness against mobile stages of lice (PAAM and adult female) as compared to juvenile 
stages (chalimus). While this is similar to earlier studies (2¶+DOORUDQ	+RJDQV5RWKHW
al., 1996), more interestingly we report differences in efficacy for azamethiphos when using 
different treatment delivery modalities. Reduction in post-treatment lice levels was significantly 
larger in the fully-enclosed tarpaulin modality compared to the skirt-style modality, though no 
significant difference was observed between the wellboat and skirt-style modalities. This raises 
questions about the ability to objectively evaluate and compare efficacies of different 
chemotherapeutants under different treatment modalities. For example, treatment efficacy 
against PAAM in the fully-enclosed tarpaulin modality was twice that compared to the wellboat 
modality; whereas the reverse was observed for adult female stages.  
 
The dichotomy in the resulting treatment efficacies between the fully-enclosed tarpaulin and 
wellboat modalities may be due to pre-treatment differences in the abundances and composition 
(proportion) of sea lice stages for each modality. The largest reduction in post-treatment counts 
of PAAM in the fully-enclosed tarpaulin modality is partially explained by the larger proportion 
of pre-treatment PAAM stages (73%) compared to the skirt-style (62%) and wellboat (43%) 
modalities. Lower abundances and proportions of chalimus stages in both pre- and post-
treatment counts in the fully-enclosed tarpaulin modality (compared to the other two modalities) 
may further hamper post-treatment recovery of PAAM stages. This finding is also supported by a 
larger reduction of PAAM two weeks post-treatment in the fully-enclosed tarpaulin modality, in 
contrast to the other two treatment modalities. In contrast, the apparently greater effectiveness of 
azamethiphos against adult female lice in the wellboat modality is likely due to the relatively 
lower contribution of surviving pre-adult female lice within the PAAM group developing into 
post-treatment adult female lice, as evidenced by the lower (4-6 times) ratio of abundances of 
PAAM/adult female in the wellboat modality compared to the other two treatment modalities.  
 The skirt-style modality demonstrated effectiveness against only the PAM stage at one week 
post-treatment and this markedly declined, as expected, at week two post-treatment against all 
mobile stages. Post-treatment lice survival is perhaps the largest contributor to an apparent 
reduction in treatment efficacy. Faster rates of infections may result from higher pre-treatment 
infection levels of adult female and chalimus stages (Kristoffersen, 2013). This would suggest 
that re-infection occurred at a faster rate in the wellboat and skirt-style modalities. These results 
agree with the exploratory analysis using ordination plots which suggest that the largest change 
in the assemblages of sea lice following treatment was seen in the fully-enclosed tarpaulin 
modality, followed by the wellboat and, lastly, the skirt-style modality. 
 
The results from the univariate (for PAAM and adult females) and multivariate analyses are 
similar and show a significantly greater reduction in post-treatment sea lice in the fully-enclosed 
tarpaulin modality, compared to the skirt-style modality; whereas no differences were seen 
between the skirt-style and wellboat modalities. The results should, however, be treated with 
caution given the differences in infection levels, pre-treatment proportions of sea lice and 
imbalances in the data between modalities. Furthermore, modality choices and sampling 
strategies, particularly timing of sampling before and after treatment, were subject to influences 
uncontrolled by the investigators. For example, if sea lice numbers increase at multiple locations 
in the New Brunswick industry, the availability of the three wellboats becomes a deciding 
criterion.  Thus, it is difficult to conclude whether efficacies with the wellboat modality truly 
differ from the other two modalities. A better approach, where feasible, may be to model the 
levels of sea lice following treatment, for example, by modeling the counts of each stage 
following treatment based on surviving lice numbers and water temperatures, accounting for the 
effect of infection pressure in the environment (Kristoffersen et al., 2014). In our case, and given 
the limited availability of data, we followed a multivariate approach. The importance of this 
analytical tool is that it improves our interpretation and understanding of the efficacy of 
azamethiphos and its application method in the field. Furthermore, it may provide a novel and 
improved analytical tool to assess the increasing desensitization of sea lice to the most common 
delousing chemotherapeutants, including azamethiphos. 
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Table 1. The mean (+/- 95% confidence intervals) percent effectiveness (% knockdown) of 
salmosan at week 1 and week 2 post-treatment.  
Week 1 
 Chalimus PAAM Adult Females 
Skirt 5.9[-10.1,19.6] 50[44.6,55] 17[4.6,27.8] 
Tarpaulin 58.8[49,66.9] 69.4[64.8,73.5] 20.9[6.3,33.2] 
Wellboat 5.4[-20,25.6] 49.9[40.9,57.7] 45.9[36.6,53.9] 
 
Week 2 
 Chalimus PAAM Adult Females 
Skirt 13.1[-1.1,25.4] 38.2[30.9,44.9] -13.4[-28.1,-0.3] 
Tarpaulin 59.9[49.7,68.2] 82.5[79.7,85] 26.9[12.3,39.2] 
Wellboat -23.4[-51.4,-0.6] 29.4[17.9,39.5] 42.8[33.8,50.7] 
 
 
Table 2a. Negative binomial model (with random effect for treatment) for abundances of 
PAAM after treatment. Covariate PAAM before treatment (PAAM, pre) was log-
transformed and centered. Days post-treatment were also centered. 
 
Variable Value Std.Error p-value 
(Intercept) 4.846 0.07 <0.001 
Log(PAAM ,pre) 1.072 0.06 <0.001 
tarpaulin -0.40 0.18 0.027 
wellboat 0.223 0.13 0.101 
Days after 
treatment 0.005 0.016 0.586 
 
The variance for the random intercept (treatment) is 0.416 and standard deviation is 
0.436.Negative binomial dispersion parameter is 3.66 for 178 treatment and 329 observations 
 
Table 2b. Negative binomial model (with random effect for treatment) for post-treatment 
abundances of AF in three modalities. Covariate PAAM and AF before treatment (PAAM, 
pre) was log-transformed and centered. Days post-treatment were also centered. 
Variable Value Std.Error p-value 
(Intercept) 4.469 0.06 <0.001 
Log(PAAM ,pre) 0.532 0.04 <0.001 
Log(AF,pre) 0.336 0.05 <0.001 
tarpaulin -0.25 0.15 0.09 
wellboat -0.03 0.12 0.772 
Days after 
treatment 0.04 0.01 0.586 
 
The variance for the random intercept (treatment) is 0.249 and standard deviation is 0.499. 
Negative binomial dispersion parameter is 4.30 for 178 treatment and 329 observations 
 Table 3. Summary of the negative binomial multivariate model assuming a shrink 
correlation matrix. The model shows the effect of treatment modalities after controlling for 
the abundances of PAAM and AF before treatment and the interval (in days) between 
treatment and sampling post-treatment. 
Variable Wald value 
Wald 
Pr(>wald) 
(Intercept) 106.9  
Log(AF,pre) 17.1 0.002 
Log(PAAM,pre) 20.1 0.002 
Tarpaulin 5.2 0.002 
Wellboat 1.5 0.344 
Interval (days) 4.3 0.002 
Test-statistic : 29.41 , p-value=0.002 
Test statistics calculated assuming a correlation matrix shrunk by parameter =0.85, P-value 
calculated using 499 resampling iterations via pit.trap. 
 
 
 
Figure 1. The proportion of individuals in each sea lice stage.  
Each bar represents the proportion of lice (from cage medians) between treatment 
modalities and sampling times. 
 
 
 
 
 
 
Figure 2a-c. Ordination plots using Principal Component Analysis median (ABC) 
abundances of lice stage groups by treatment modalities at pre and post-treatment (n=486). 
In total 21 treatments were not included because of missing data for chalimus. The 
proportion of the total variance explained by the two main principal components (first and 
second axes) is 0.85 (skirt), 0.94 (wellboat) and 0.79 (tarpaulin).  
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B)  Wellboat 
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C) Skirt 
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